Clinical trial
A Randomised Placebo-controlled Trial of Fenofibrate to Prevent Progression of Non-proliferative Retinopathy in Diabetes
NCT03439345 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Placebo-controlled Trial of Fenofibrate to Prevent Progression of Non-proliferative Retinopathy in Diabetes
- Lead sponsor
- University of Oxford
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 23, 2018
- Completion date
- February 16, 2024
- Enrollment
- 1,151 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.